文献速递脊柱关节炎其他结缔组织病

银屑病关节炎患者抑郁与焦虑的流行病学:系统综述与荟萃分析

Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis.
PubMed 文献 · Semin Arthritis Rheum · 2020-02-13

该系统综述与荟萃分析纳入18项观察性研究,评估银屑病关节炎(PsA)患者抑郁和焦虑的患病率、发病率及药物治疗情况。汇总抑郁患病率为17%(95%CI 13%–21%),焦虑患病率为19%(95%CI 11%–29%),且PsA患者抑郁风险显著高于非PsA人群(OR 1.68,95%CI 1.37–2.08)。仅2.4%–13.5%的患者报告使用抗抑郁或抗焦虑药物。

要点

  • PsA患者抑郁汇总患病率为17%,焦虑为19%。
  • PsA患者抑郁风险高于非PsA人群(OR 1.68,95%CI 1.37–2.08)。
  • 仅2.4%–13.5%的PsA患者使用抗抑郁或抗焦虑药物。

核心结论

  • PsA患者中抑郁和焦虑患病率较高,且抑郁发病率升高,应重视该人群的精神卫生保健。

研究设计与样本

  • 系统综述与荟萃分析,检索Medline、Embase、Cochrane Database of Systematic Reviews、CINAHL和PsycINFO,纳入18项观察性研究。

主要发现

  • 基于11项研究的抑郁汇总患病率为17%(95%CI 13%–21%)。
  • 4项比较PsA与非PsA人群的研究显示抑郁汇总OR为1.68(95%CI 1.37–2.08)。
  • PsA患者抑郁汇总发病率为21.27/1000人年(95%CI 16.28–26.27),发病率比为1.44(95%CI 1.20–1.73)。
  • 基于7项研究的焦虑汇总患病率为19%(95%CI 11%–29%)。
  • 2项比较PsA与非PsA人群的研究显示焦虑汇总OR为1.49(95%CI 1.39–1.59)。

关键数值与推荐

  • 仅2.4%–13.5%的PsA患者报告使用抗抑郁或抗焦虑药物。

临床怎么用

  • 风湿免疫科医生应关注PsA患者的心理健康筛查,并注意抗抑郁/抗焦虑药物使用比例较低的情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To conduct a systematic review and meta-analysis of the prevalence, incidence, and medication treatment of depression and anxiety among patients with psoriatic arthritis (PsA). METHODS: We searched Medline, Embase, Cochrane Database of Systematic Reviews, CINAHL and PsycINFO for full-length studies that: utilized an observational design; included patients with PsA with/without a comparator group; evaluated depression and/or anxiety as an outcome, comorbidity, or predictor of a health outcome; and reported relevant estimates. We pooled estimates using random effects models. RESULTS: Of 683 titles identified in our search, 18 studies met inclusion criteria. The pooled prevalence proportion for depression based on 11 studies was 17% (95% confidence interval [CI], 13% to 21%). In addition, a meta-analysis of four studies comparing the prevalence of depression in patients with PsA to those without PsA yielded a pooled odds ratio (OR) of 1.68 (95% CI, 1.37 to 2.08). The incidence of depression in PsA patients compared to the general population yielded a pooled incidence rate of 21.27 (95% CI, 16.28 to 26.27) per 1,000 person-years and a pooled incidence rate ratio of 1.44 (95% CI, 1.20 to 1.73). The pooled prevalence proportion of anxiety based on seven studies was 19% (95% CI, 11% to 29%) and a meta-analysis of two studies comparing the prevalence of anxiety in patients with PsA to those without PsA yielded a pooled OR of 1.49 (95% CI, 1.39 to 1.59). Only a small proportion of patients, between 2.4% and 13.5%, were reported to be taking antidepressant or antianxiety medications. CONCLUSIONS: We identified substantial prevalence of depression and anxiety as well as elevated incidence of depression among patients with PsA. These findings should raise awareness of the importance of mental health care in this population.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Zusman EZ, Howren AM, Park JYE, et al. Epidemiology of depression and anxiety in patients with psoriatic arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2020. PMID: 32178850. doi:10.1016/j.semarthrit.2020.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。